Company news
Aeolus Pharmaceuticals Inc news in 2016
Aeolus Pharmaceuticals Inc's news releases, calls and decks from 2016, newest first.
Aeolus Announces Fiscal Year 2016 Financial Results
December 21, 2016
Aeolus Announces Publication of Additional Data Demonstrating Efficacy of AEOL 10150 in Sulfur Mustard Exposure in Journal "Toxicological Sciences"
September 19, 2016
Aeolus Announces Positive Data Confirming Efficacy of AEOL 10150 as a Medical Countermeasure Against Sulfur Mustard Gas
September 6, 2016
Aeolus Pharmaceuticals to Present at Aegis Growth Conference on September 22, 2016
August 31, 2016
Aeolus Announces Third Quarter Fiscal Year 2016 Financial Results
August 15, 2016
StockNewsNow.com Publishes New SNNLive Video Interview with Aeolus Pharmaceuticals, Inc. Discussing Clinical Development and Milestones for 2016-2017
July 7, 2016
Aeolus Pharmaceuticals to Present at LD Micro Invitational Conference
May 24, 2016
European Patent Issued and Patent Allowed in Japan for Aeolus' Parkinson's Disease Compound AEOL 11114
April 18, 2016
Aeolus Announces Removal of FDA Clinical Hold on AEOL 10150; Initiation of Phase 1 Study in Healthy Volunteers Planned for 2nd Quarter 2016
February 22, 2016
Aeolus Announces First Quarter Fiscal Year 2016 Financial Results
February 16, 2016